We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Eating Flavonoids-Rich Foods May Protect Men Against Parkinson’s

By LabMedica International staff writers
Posted on 17 Apr 2012
Print article
Men who eat flavonoid-rich foods such as apples, berries, tea, and red wine considerably reduce their risk of developing Parkinson’s disease (PD).

Published April 4, 2012, in the journal Neurology, the study’s findings supplement the growing evidence that regular consumption of some flavonoids can have a distinct effect on health. Recent studies have shown that these compounds can provide protection against a wide range of diseases including heart disease, hypertension, various cancers, and dementia.

This latest study, conducted by investigators from by Harvard University (Cambridge, MA, USA) and the University of East Anglia (UEA; Norwich, UK) is the first study in humans to demonstrate that flavonoids can protect neurons against diseases of the brain such as Parkinson’s.

Approximately 130,000 men and women were enrolled in the study. More than 800 had developed PD within 20 years of follow-up. After a comprehensive analysis of their diets and adjusting for age and lifestyle, male participants who ate the most flavonoids were shown to be 40% less likely to develop the disease than those who ate the least. No similar association was found for total flavonoid intake in women.

The research was led by Dr. Xiang Gao of Harvard School of Public Health in collaboration with Prof. Aedin Cassidy, from the department of nutrition, Norwich Medical School at UEA. “These exciting findings provide further confirmation that regular consumption of flavonoids can have potential health benefits,” said Prof. Cassidy. “This is the first study in humans to look at the associations between the range of flavonoids in the diet and the risk of developing Parkinson’s disease and our findings suggest that a subclass of flavonoids called anthocyanins may have neuroprotective effects.”

Dr. Gao said, “Interestingly, anthocyanins and berry fruits, which are rich in anthocyanins, seem to be associated with a lower risk of Parkinson’s disease in pooled analyses. Participants who consumed one or more portions of berry fruits each week were around 25% less likely to develop Parkinson’s disease, relative to those who did not eat berry fruits. Given the other potential health effects of berry fruits, such as lowering risk of hypertension as reported in our previous studies, it is good to regularly add these fruits to your diet.”

Flavonoids are a group of naturally occurring, bioactive compounds found in many plant-based drinks and foods. In this study, the key protective effect was from higher intake of anthocyanins, which are present in berries and other fruits and vegetables including eggplant, blackcurrants, and blackberries. Those who consumed the most anthocyanins had a 24 per cent reduction in risk of developing PD and strawberries and blueberries were the top two sources in the diet in the United States.

The results must now be validated by other large epidemiologic studies and clinical trials, according to the investigators. PD is a progressive neurologic condition affecting one in 500 people, which equates to 127,000 people in the United Kingdom. There are few effective drug therapies available.

Dr. Kieran Breen, director of research at Parkinson’s UK (London), said, “This study raises lots of interesting questions about how diet may influence our risk of Parkinson’s and we welcome any new research that could potentially lead to prevention. “While these new results look interesting there are still a lot of questions to answer and much more research to do before we really know how important diet might be for people with Parkinson’s.”

Related Links:

Harvard University
University of East Anglia
Parkinson’s UK


Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Quantitative Immunoassay Analyzer
AS050
New
Serum Toxicology Benzodiazepine Assay
DRI Serum Toxicology Benzodiazepine Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.